Predictive Modeling and Machine Learning: Sharpening the Focus of Real-World Evidence in the Age of Precision Medicine

The challenge of real-world evidence in the age of precision medicine Real-world evidence is being used increasingly to provide important information about natural history of a disease, drug utilization and treatment patterns, comorbidities, safety and effectiveness of medications, along with… Continue Reading

The things you need to know about the digital transformation of primary research

In the rapidly evolving market access landscape, it’s important to quickly identify current payer perspectives to determine future trends. High-quality, rapid primary research can be key to fast-forwarding your strategy. Continue Reading

Payer and HTA submissions: how digital technology is transforming market access processes

In the first of her five-part series on digital transformation in market access, Dr Patti Peeples, CEO of HealthEconomics.com, sits down with Claire Chadwick, HTA Manager at PRMA Consulting. Continue Reading

Tackling Rare Diseases with an Arsenal of Real-World Data

Technological innovations have fostered the age of big data in healthcare – and the huge populations amassed afford the ability to mine for key subpopulations — getting down to ever more precise groups of likely responders to therapy, high-risk patients and other high-value subphenotypes. Continue Reading